Is Dianthus Therapeutics, Inc. (DNTH) a Buy, Sell, or Hold?
Dianthus Therapeutics, Inc.
NASDAQ:DNTH
$101.28 USD
$2.64 (2.68%)
- Volume
- 1.17M
- Average Volume
- 937.49K
- Market Capitalization
- $4.23B
- P/E Ratio
- -920.73
- Dividend Yield
- 0.00%
- Price Target
- $120.00
- Year High
- $102.37
- Year Low
- $18.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $29.25
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-15.6% DOWNSIDE
$120.00 Price Target
UPSIDE/DOWNSIDE HIGH
-30.2% DOWNSIDE
$145.00 Price Target High
UPSIDE/DOWNSIDE LOW
84.1% UPSIDE
$55.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Evercore ISI | Gavin Clark-Gartner | $120 | $88.45 | 2026-05-11 08:04 AM | 35.7% |
| Wolfe Research | Andy Chen | $98 | $87.48 | 2026-04-08 04:38 PM | 12.0% |
| UBS | Maury Raycroft | $98 | $79.23 | 2026-03-09 03:56 PM | 23.7% |
| Jefferies | Maury Raycroft | $98 | $79.23 | 2026-03-09 03:51 PM | 23.7% |
| H.C. Wainwright | Swayampakula Ramakanth | $130 | $79.23 | 2026-03-09 12:04 PM | 64.1% |
| Oppenheimer | Trevor Allred | $145 | $80.8806 | 2026-03-09 10:15 AM | 79.3% |
| Stifel Nicolaus | Alex Thompson | $120 | $80.5985 | 2026-03-09 10:14 AM | 48.9% |